Form 4: Pro Dex Inc. Director Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Raymond E. Cabillot, a director and 10% owner of Pro Dex Inc., sold 7,263 shares of common stock at a weighted average price of $50.01, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Raymond E. Cabillot, a director and 10% owner of Pro Dex Inc. (PDEX), reported a transaction involving the sale of company stock.
- The transaction occurred on April 1, 2025.
- Cabillot sold 7,263 shares of common stock at a weighted average price of $50.01.
- The sales were executed under a Rule 10b5-1 trading plan adopted on September 20, 2024.
- Following the transaction, Cabillot directly owns no shares and indirectly owns 270,846 shares through Farnam Street Partners, L.P.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was executed under a pre-arranged trading plan, indicating it was likely planned and not necessarily indicative of the director's current outlook on the company.
Industry Context
Sales by company insiders are routinely monitored by investors. Sales under a 10b5-1 plan are generally viewed as less impactful than discretionary sales, as they are pre-arranged.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the use of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 04/01/2025 | Date of the stock sale transaction |
Keywords
Form 4, PDEX, Pro Dex Inc, Cabillot, Raymond E. Cabillot, Farnam Street Partners, 10b5-1 trading plan, stock sale, director, 10% owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.